Urinary Protein to Creatinine Ratio in Term Pregnant Women
1 other identifier
interventional
240
1 country
1
Brief Summary
This study will determine the incidence of elevated U Pr/Cr in normal term pregnant women. In addition we will determine if a "clean catch" urine has an effect on the U Pr/Cr.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 31, 2018
CompletedStudy Start
First participant enrolled
September 1, 2018
CompletedFirst Posted
Study publicly available on registry
September 7, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2019
CompletedSeptember 7, 2018
September 1, 2018
11 months
August 31, 2018
September 6, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
elevated PR/CR ratio using clean catch technique
this will be the proportion of patients with PR/CR ratio greater than or equal to 0.3 in urine using a clean catch method.
through study completion, an average of 1 year
Secondary Outcomes (1)
Report the incident of PR/CR ratio greater than 0.3
through study completion, average of 1 year
Study Arms (2)
Clean catch
EXPERIMENTALwomen in this group will collect urine for PR/CR using a clean catch technique
Non-clean catch
PLACEBO COMPARATORwomen in this group will not employ clean catch technique
Interventions
clean catch technique applied to collect urine for PR/CR ratio
Eligibility Criteria
You may qualify if:
- women of 37 weeks gestation or greater
You may not qualify if:
- Urinary tract infections
- Hypertension
- Pre-eclampsia
- Renal dysfunction
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St Luke's University Hospital
Bethlehem, Pennsylvania, 18015, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
James N Anasti, MD
St Luke's University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor of OB/GYN
Study Record Dates
First Submitted
August 31, 2018
First Posted
September 7, 2018
Study Start
September 1, 2018
Primary Completion
August 1, 2019
Study Completion
November 1, 2019
Last Updated
September 7, 2018
Record last verified: 2018-09